Literature DB >> 30194942

Dihydromyricetin from ampelopsis grossedentata protects against vascular neointimal formation via induction of TR3.

Baohua Huang1, Yaping Li1, Yanling Yao1, Wei Shu2, Ming Chen1.   

Abstract

Vine tea has been used as a medicinal herb in traditional Chinese medicine for hundreds of years. As the most abundant ingredient in vine tea, Dihydromyricetin (DHM) has been reported to exert anti-inflammatory, antioxidant, and anti-cardiovascular disease. However, the role of DHM in injury-induced neointimal formation remains poorly characterized. We determined the effects of DHM on ligation-induced carotid artery neointimal formation. We found that ligation-induced carotid artery neointimal formation could be significantly attenuated by DHM treatment. We provide evidence that DHM increases orphan nuclear receptor TR3 expression in smooth muscle cell (SMC) and carotid artery. Moreover, overexpression and loss-of-function strategies of TR3 were done to overexpression and knockdown of TR3, and demonstrate that DHM promotes SMC differentiation, however, inhibits SMC proliferation and migration, via regulating expression of TR3. Collectively, we reveal that DHM may be a therapeutic agent for the treatment of injury-induced vascular diseases.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dihydromyricetin; Neointimal formation; Smooth muscle cell; TR3

Mesh:

Substances:

Year:  2018        PMID: 30194942     DOI: 10.1016/j.ejphar.2018.09.002

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Dihydromyricetin Improves Endothelial Dysfunction in Diabetic Mice via Oxidative Stress Inhibition in a SIRT3-Dependent Manner.

Authors:  Yu-Yun Hua; Yue Zhang; Wei-Wei Gong; Yue Ding; Jie-Ru Shen; Hua Li; Yun Chen; Guo-Liang Meng
Journal:  Int J Mol Sci       Date:  2020-09-13       Impact factor: 5.923

Review 2.  Mechanism of Dihydromyricetin on Inflammatory Diseases.

Authors:  Yang Sun; Shasha Liu; Songwei Yang; Chen Chen; Yantao Yang; Meiyu Lin; Chao Liu; Wenmao Wang; Xudong Zhou; Qidi Ai; Wei Wang; Naihong Chen
Journal:  Front Pharmacol       Date:  2022-01-18       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.